AssayIndex
Reports by quarter

Reports submitted in 2026-Q2 · page 9

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 99.00 % area, n=1126. Read the 2026-Q2 state-of-the-index report →

1,126 records29 pagesmedian on this page 98.90 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043172BPC-157GL BiochemGLBI-2602-T8050PeptideMeter2026-Q298.443.8497.7Buyer-sourced1MARGINAL
AX-2026-043081TirzepatideKPKP-2602-X6001Janoshik2026-Q298.796.66103.8Buyer-sourced0PASS
AX-2026-043018CJC-1295 (no DAC)MKMMKM-2512-Y4110Medutest2026-Q298.414.18104.4Buyer-sourced0PASS
AX-2026-043001SemaglutideMKMMKM-2601-Y4342Kestrel2026-Q298.903.5996.5Buyer-sourced0PASS
AX-2026-042777SemaxGGPepsGGPE-2512-Y1048Janoshik2026-Q299.227.44—Buyer-sourced0PASS
AX-2026-042548GHRP-2HJHJ-2602-W6219Janoshik2026-Q299.181.3191.3Buyer-sourced0PASS
AX-2026-042546GHRP-2HJHJ-2602-W6219PeptideMeter2026-Q299.051.2289.1Buyer-sourced1MARGINAL
AX-2026-042035SemaglutideHYBHYB-2511-F6451Janoshik2026-Q299.131.7895.1Buyer-sourced0PASS
AX-2026-041744CagrilintideTFSTFS-{CAT}-1681Janoshik2026-Q299.725.23—Buyer-sourced0PASS
AX-2026-041634MK-677 (Ibutamoren mesylate)FGPFGP-2604-K8509PeptideMeter2026-Q299.865.17—Buyer-sourced0FAIL
AX-2026-041295SemaglutideWWBWWB-2603-N3120PeptideMeter2026-Q299.076.35—Buyer-sourced1MARGINAL
AX-2026-043617TirzepatidePPGPPG-2602-G7459Janoshik2026-Q298.944.36103.6Buyer-sourced0PASS
AX-2026-043309TB-500CPCCPC-2605-B1397PeptideMeter2026-Q299.035.60—Buyer-sourced0PASS
AX-2026-043304RetatrutideCPCCPC-2604-H1694VendorInvestigate2026-Q297.223.43—Buyer-sourced0PASS
AX-2026-043243GHK-CuCPCCPC-2601-D1258Medutest2026-Q298.196.2898.0Supplier-supplied1FAIL
AX-2026-043162GHK-CuSSASSA-2604-V7731Janoshik2026-Q298.504.36—Supplier-supplied0PASS
AX-2026-043032SemaglutideKPKP-2601-K5213PeptideMeter2026-Q298.395.16107.4Buyer-sourced0PASS
AX-2026-042779SemaxGGPepsGGPE-2512-Y1048Kestrel2026-Q299.937.34—Supplier-supplied0PASS
AX-2026-042386TirzepatideHomopeptideHOMO-2601-N4081Janoshik2026-Q298.904.85105.6Buyer-sourced0PASS
AX-2026-042346ARA-290HomopeptideHOMO-2601-T3123PeptideMeter2026-Q299.703.47—Buyer-sourced0PASS
AX-2026-041995Thymosin α1AMBAMB-2511-B5683PeptideMeter2026-Q298.864.00104.5Buyer-sourced0PASS
AX-2026-041883SemaglutideSinoPepSNP-2511-P4283Medutest2026-Q298.253.96—Buyer-sourced0PASS
AX-2026-041839BPC-157GSPGSP-2512-E2935Medutest2026-Q299.415.23—Buyer-sourced1FAIL
AX-2026-041675RetatrutideTFSTFS-{CAT}-9709Janoshik2026-Q298.203.37—Buyer-sourced0PASS
AX-2026-041657TirzepatideFGPFGP-2605-R8870Janoshik2026-Q298.006.56—Buyer-sourced0PASS
AX-2026-043620TirzepatidePPGPPG-2602-G7459PeptideMeter2026-Q299.364.26100.2Buyer-sourced0PASS
AX-2026-043266IGF-1 LR3CPCCPC-2512-S1358Janoshik2026-Q298.023.22—Laboratory-retained0PASS
AX-2026-043262TirzepatideCPCCPC-2605-P1014Medutest2026-Q297.284.5889.4Laboratory-retained1MARGINAL
AX-2026-042893BPC-157GGPepsGGPE-2602-N2621Janoshik2026-Q299.475.04104.8Supplier-supplied1MARGINAL
AX-2026-042586BPC-157HJHJ-2511-U6485Janoshik2026-Q298.745.6399.9Buyer-sourced0PASS
AX-2026-042545AOD-9604HJHJ-2601-N5554Nordanalyt2026-Q298.845.5690.8Buyer-sourced0PASS
AX-2026-042243BPC-157TFCTFC-2604-A9366Nordanalyt2026-Q299.545.61—Laboratory-retained0PASS
AX-2026-042136PT-141 (Bremelanotide)JEEPJEEP-2601-K8195Kestrel2026-Q299.323.93105.8Buyer-sourced1MARGINAL
AX-2026-041828SemaglutideGSPGSP-2512-H2838Nordanalyt2026-Q298.406.08102.4Buyer-sourced0PASS
AX-2026-041693SemaglutideTFSTFS-{CAT}-9391Janoshik2026-Q299.154.92—Laboratory-retained0PASS
AX-2026-041303IpamorelinWWBWWB-2604-E3153Janoshik2026-Q299.935.36107.1Buyer-sourced0PASS
AX-2026-043334BPC-157CPCCPC-2601-M1478PeptideMeter2026-Q298.135.8091.8Buyer-sourced0PASS
AX-2026-042567IpamorelinHJHJ-2604-T6645Janoshik2026-Q298.505.48—Buyer-sourced1FAIL
AX-2026-042559TirzepatideHJHJ-2605-D6191VendorInvestigate2026-Q298.144.2293.5Buyer-sourced1MARGINAL
AX-2026-042532BPC-157HJHJ-2511-P5900Janoshik2026-Q299.352.9495.7Buyer-sourced0PASS